Cannabis Law Report

JULY 13, 2022

Their position as therapeutic practitioners, as well as their work in conducting the kind of clinical trials necessary to advance regulatory outcomes for psychedelic medicines, make them ideal partners in alignment with Optimi’s strategic goals.”. VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (

Therapy 52

Therapy Clinical Trials Microdosing Research and Development 52

Canna Law Blog

NOVEMBER 15, 2021

Microdose hosted its annual psychedelics conference in Miami last week (appropriately titled “Wonderland”). There was a fascinating panel on the use of ketamine treatments for, among other things, depression and anxiety disorders. Pharmaceutical start-ups are betting on the treatment potential of psychedelics.

Clinical Trials 98

Clinical Trials Treatment Microdosing Pharmaceutical 98

The Cannigma

DECEMBER 12, 2022

Scientists are hopeful that psychedelics might have more of a curative effect when it comes to mental health than many existing treatment options; meaning that unlike most psychiatric medications, psychedelics may be able to prompt long-term changes to our mental state with only a few doses. What is microdosing? Are psychedelics safe?

History 119

History Microdosing Research and Development Clinical Trials 119

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. in/ronanlevy/. Bia Labate.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51